BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,529 | +1047.5% | 130 | +1344.4% | 0.00% | – |
| Q2 2023 | $569 | +40.5% | 9 | 0.0% | 0.00% | – |
| Q1 2023 | $405 | – | 9 | +50.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 6 | -71.4% | 0.00% | – |
| Q1 2022 | $1,000 | -93.8% | 21 | -85.8% | 0.00% | -100.0% |
| Q4 2021 | $16,000 | +6.7% | 148 | -1.3% | 0.00% | 0.0% |
| Q3 2021 | $15,000 | +650.0% | 150 | +614.3% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 21 | -34.4% | 0.00% | – |
| Q1 2021 | $3,000 | +50.0% | 32 | +52.4% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 21 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | +100.0% | 21 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 21 | -38.2% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 34 | +54.5% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 22 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 22 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | +100.0% | 22 | +37.5% | 0.00% | – |
| Q2 2018 | $1,000 | – | 16 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |